文献速递产科母胎医学

阿司匹林治疗对妊娠早中期子宫动脉阻力和胎盘生长的调节作用

Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-09-20

前瞻性观察队列纳入631例单胎妊娠,53例(8.4%)早发型子痫前期高危孕妇服用低剂量阿司匹林。与未治疗低危组相比,用药组早中期胎盘更小、子宫动脉搏动指数更高,但两次孕期之间子宫动脉搏动指数下降幅度更大,胎盘生长无显著差异。

要点

  • 早发型子痫前期高危孕妇早中期胎盘体积小于未治疗低危组,子宫动脉搏动指数更高。
  • 低剂量阿司匹林未影响早中期胎盘生长,但与子宫动脉搏动指数下降幅度更大相关。
  • 用药组剖宫产率高于未治疗组(38.5% vs 21.1%,P=0.008),围产结局相似。

核心结论

  • 早发型子痫前期高危孕妇在早中期胎盘较小且子宫动脉搏动指数较高;低剂量阿司匹林未影响胎盘生长,但与子宫动脉搏动指数下降幅度更大相关,提示对胎盘灌注有积极作用。

研究设计与样本

  • 前瞻性观察队列研究,纳入631例单胎妊娠,通过母体因素或多变量筛查方案识别早发型子痫前期(分娩≤33+6周)高危孕妇并处方低剂量阿司匹林。
  • 采用二维和三维超声评估胎盘大小,经腹多普勒测量子宫动脉搏动指数,于早孕期和中孕期测量。
  • 比较服用低剂量阿司匹林的高危孕妇与未治疗低危孕妇的胎盘测量值和子宫动脉搏动指数差异。

主要发现

  • 631例中53例(8.4%)因预防早发型子痫前期服用低剂量阿司匹林。
  • 早孕期低剂量阿司匹林组胎盘体积小于未治疗组(均值±标准差,68.46±25.19 cm3 vs 76.31±23.63 cm3;P=0.022),该趋势持续至中孕期。
  • 两组早孕期至中孕期胎盘生长无显著差异。
  • 低剂量阿司匹林组两个孕期子宫动脉搏动指数均显著更高,但两次孕期之间子宫动脉搏动指数中位数倍数下降幅度更大(均值±标准差,-14.0±0.28% vs -4.5±0.31%;P=0.021)。
  • 除低剂量阿司匹林组剖宫产率更高外(38.5% vs 21.1%;P=0.008),两组围产结局相似。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of low-dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA-PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early-onset pre-eclampsia (PE). METHODS: This was a prospective observational cohort study of 631 singleton pregnancies. Women at high risk of early-onset PE (delivery ≤ 33 + 6 weeks) were identified using maternal factors or a multivariate screening protocol and were prescribed LDA. Placental size was assessed using two- and three-dimensional ultrasonography, and UtA-PI was measured using transabdominal Doppler, with measurements obtained in the first and second trimesters. Differences in placental measurements and UtA-PI between high-risk women receiving LDA and low-risk untreated women were analyzed. RESULTS: Among the 631 participants, 53 (8.4%) women were prescribed LDA for the prevention of early-onset PE. Placental size in the first trimester was significantly smaller in the LDA group compared with the untreated group, as exemplified by placental volume (mean ± SD, 68.46 ± 25.19 cm3 vs 76.31 ± 23.63 cm3; P = 0.022), and this trend persisted into the second trimester. However, no significant differences in placental growth from the first to the second trimester were observed between the groups. UtA-PI was significantly higher in the LDA group in both trimesters, but a greater decrease in UtA-PI multiples of the median values between trimesters was noted in these women (mean ± SD, -14.0 ± 0.28% vs -4.5 ± 0.31%; P = 0.021). Perinatal outcomes were similar between the groups, with the exception of a higher rate of Cesarean delivery in the LDA group (38.5% vs 21.1%; P = 0.008). CONCLUSIONS: Women at high risk for early-onset PE have a smaller placenta and higher UtA-PI in the first and second trimesters. Treatment of high-risk women with LDA did not affect placental growth but was associated with a greater reduction in UtA-PI, suggesting a positive effect of LDA on placental perfusion. These findings provide insight into the mechanism of action of LDA in the prevention of PE. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Trilla C, Platero J, Mora J, et al. Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy. Ultrasound Obstet Gynecol. 2025. PMID: 40974599. doi:10.1002/uog.70095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。